Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | SCPH | PRQR | ||
| Company | Cellectis S.A. ADR | SC Pharmaceuticals Inc | Proqr Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.89 | 4.76 | 1.99 | ||
| High | 3.09 | 4.85 | 2.05 | ||
| Low | 2.89 | 4.54 | 1.97 | ||
| Last | 2.99 | 4.66 | 2.01 | ||
| Change | unch | unch | +0.02 | ||
| % Change | unch | unch | +1.01% | ||
| Volume | 90,800 | 159,900 | 215,600 | ||
| 20-Day Average Volume | 56,105 | 156,285 | 172,105 | ||
| Previous Close | 2.99 | 4.66 | 1.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.63 | 4.66 | 2.05 | ||
| 20-Day Raw Stochastic | 87.34% | 46.59% | 30.77% | ||
| 20-Day Relative Strength | 62.21% | 45.31% | 46.78% | ||
| Weighted Alpha | -29.39 | -56.35 | +1.23 | ||
| Today's Opinion | 72% Buy | 96% Sell | 8% Buy | ||
| Previous Opinion | 72% Buy | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 32% Buy | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.33% since 04/26/24 | +3.79% since 04/26/24 | +3.61% since 04/26/24 | ||
| Low | 2.37 on 04/29/24 | 4.40 on 04/30/24 | 1.85 on 05/01/24 | ||
| High | 3.09 on 05/03/24 | 4.85 on 05/03/24 | 2.05 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +7.17% since 04/03/24 | -10.56% since 04/03/24 | -5.41% since 04/03/24 | ||
| Low | 2.30 on 04/18/24 | 4.25 on 04/18/24 | 1.81 on 04/18/24 | ||
| High | 3.09 on 05/03/24 | 5.33 on 04/04/24 | 2.46 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +1.36% since 02/02/24 | -5.09% since 02/02/24 | -5.63% since 02/02/24 | ||
| Low | 2.30 on 04/18/24 | 4.25 on 04/18/24 | 1.81 on 04/18/24 | ||
| High | 3.13 on 02/08/24 | 6.54 on 02/27/24 | 2.70 on 03/15/24 | ||
| 6-Month | |||||
| %Chg | +4.55% since 11/03/23 | -13.06% since 11/03/23 | +66.12% since 11/03/23 | ||
| Low | 2.30 on 04/18/24 | 4.25 on 04/18/24 | 1.18 on 11/27/23 | ||
| High | 3.77 on 12/20/23 | 6.71 on 12/22/23 | 3.29 on 01/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 166,196 | 168,012 | 163,524 | ||
| Shares Outstanding, K | 55,584 | 36,054 | 81,355 | ||
| Annual Sales | 25,730,000 | 13,590,000 | 7,050,000 | ||
| Annual Net Income | -106,140,000 | -54,810,000 | -30,430,000 | ||
| Last Quarter Sales | 1,640,000 | 6,100,000 | 3,540,000 | ||
| Last Quarter Net Income | -17,480,000 | -13,810,000 | -5,920,000 | ||
| 60-Month Beta | 3.08 | 0.09 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 04/29/24 | -0.35 on 03/13/24 | -0.08 on 03/13/24 | ||
| Latest Earnings Date | 05/02/24 | 05/08/24 | 05/21/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||